跳至主要内容
临床试验/CTRI/2022/10/046596
CTRI/2022/10/046596尚未招募不适用

A Comparative Clinical Study Of Kutajashtak Churna And Samangadi Kwath On Asrigdara W.S.R. To Menometrorrhagia

Madan Mohan Malviya Govt Ayurved college1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年11月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
improvement in the sign & symptoms from the treatment in the patients

研究概览

简要总结

this study is about comparing the effect of kutajashtak churna and samangadi kwath in the management of asrigdara w.s.r. to Menometrorrhagia . there will be two groups of 20-20 patients in which group A patients will be treated with kutajashtak churna 5gm orally BD with ghrita and sharkara . group B patients will be treated with  kutajashtak churna (5gm) with samangadi kwath (40ml) orally BD for three consecutive menstrual cycles.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1 patients willing for the trial 2 patients between the age group of 18-45 years 3 patients with either one or all symptoms of Asrigdara like Ritu Atipravritti (excessive bleeding during menstruation) Deergha Pravritti (prolonged bleeding).

排除标准

  • 1 patients before 18 years and after 45 years of age 2 patients with uterine and pelvic pathology like big fibroid carcinoma cervix cervical polyp endometrial carcinoma chronic medical illness etc 3 bleeding due to coagulation disorders 4 patients had bleeding due to abortions.

结局指标

主要结局

improvement in the sign & symptoms from the treatment in the patients

时间窗: 3 months

次要结局

  • efficacy of treatment(3 months)

研究者

发起方
Madan Mohan Malviya Govt Ayurved college
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验